Research funding

Research & development at EUROIMMUN is supported by the European Regional Development Fund (ERDF). At our branch in Dassow (Mecklenburg-Vorpommern) a project is funded from 2014 to mid 2017 which aims at resolving the technical difficulties during storage and handling of particles for analyses in automated pipetting stations. The intention is to offset disadvantages of conventional solutions by using single doses of particles in capillaries for higher reproducibility of the analyses and better stability of the reagents. To meet these requirements, we develop specific technical system components (capillary, stack, cartridge) as well as the filling process for the capillaries.

Annother funded project in Dassow focuses on peptide-based diagnoses of food allergies. The central task of this project is the identification of molecular target structures of the allergy-specific antibodies based on clinically characterised patient sera. These amino acid sequences are then applied as antigens in a novel serological test system for the diagnosis of food allergies. Differentiation, prognosis and therapy of food allergies shall be helped by the characterisation of the epitopes. The peptide-based multiparameter test shall enable diagnosis of severe symptoms and replace risky provocation tests.

The project EUROPathology System (EPS) encompasses the development of new methodical approaches for histopathology. EPS will incorporate all important steps from production of tissue sections to evaluation and documentation of results. The system will be composed of modules designed for each phase of the workflow, from sample entry to issuing and archiving of results. 

Moreover, the fund supports a joint research project with the University of applied sciences Zittau/Goerlitz at our site in Rennersdorf (Saxony). The aim is to develop a robust technology platform for the cost-effective and resource-saving production of immunologically reactive proteins.
The University of applied sciences Zittau/Goerlitz develops continuous and automatable production techniques producing biomaterial extracts which can be processed and subsequently serve as source material for chromatographic purification. EUROIMMUN performs the molecular biological and immunobiochemical works which are then included in the development of the matrices for the protein purification. These are then combined in a one-step chromatography process. In the end, biomaterial preparation and chromatography process are combined to produce immunoreagents of high quality, in one process step.